Sign in

CIK 0001566044

  • Non-accelerated filer
  • Smaller reporting company

Yarrow Bioscience, Inc.

Sign in to watch
Ticker
YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453757789
Phone
+1 203-433-7577
Business address
470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
Former names
VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 2 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-05-31 Zeronda Tyler CFO Grant or award +12,510 $0.35 $4K 174,066
2022-05-31 Domzalski David President and CEO Grant or award +11,887 $0.35 $4K 1,061,636
2022-03-31 Zeronda Tyler CFO Shares withheld for taxes −773 $0.65 $502 161,556
2022-03-31 Stuart Iain Chief Scientific Officer Shares withheld for taxes −3,469 $0.65 $2K 225,410
2022-03-31 Harsch Mutya Chief Legal Officer and GC Shares withheld for taxes −3,630 $0.65 $2K 234,583
2022-03-31 Domzalski David President and CEO Shares withheld for taxes −23,186 $0.65 $15K 1,049,749
2022-03-17 Zeronda Tyler CFO Grant or award +75,000 162,329
2022-03-17 Zeronda Tyler CFO Grant or award · Stock Options +75,000 75,000
2022-03-17 Stuart Iain Chief Scientific Officer Grant or award +75,000 228,879
2022-03-17 Stuart Iain Chief Scientific Officer Grant or award · Stock Options +75,000 75,000
2022-03-17 Harsch Mutya Chief Legal Officer and GC Grant or award +75,000 238,213
2022-03-17 Harsch Mutya Chief Legal Officer and GC Grant or award · Stock Options +75,000 75,000
2022-03-17 Domzalski David President and CEO Grant or award +312,302 1,072,935
2022-03-17 Domzalski David President and CEO Grant or award · Stock Options +312,303 312,303
2021-12-31 Zeronda Tyler Interim CFO Shares withheld for taxes −206 $1.02 $210 87,329
2021-12-31 Stuart Iain Chief Scientific Officer Shares withheld for taxes −1,250 $1.02 $1K 153,879
2021-12-31 Harsch Mutya Chief Legal Officer and GC Shares withheld for taxes −1,484 $1.02 $2K 163,213
2021-12-31 Domzalski David President and CEO Shares withheld for taxes −6,887 $1.02 $7K 760,633
2021-11-30 Zeronda Tyler Interim CFO Grant or award +4,187 $0.88 $4K 87,535
2021-11-30 LEPORE PATRICK G Director Purchase +12,500 $1.02 $13K 62,500

Page 8 of 22 · 425 trades